HomeVVOS • NASDAQ
add
Vivos Therapeutics Inc
Previous close
$2.21
Day range
$2.16 - $2.32
Year range
$1.97 - $6.28
Market cap
13.13M USD
Avg Volume
110.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.02M | -11.79% |
Operating expense | 5.43M | -5.16% |
Net income | -3.86M | -2.68% |
Net profit margin | -128.12 | -16.41% |
Earnings per share | -0.45 | 72.39% |
EBITDA | -3.74M | -2.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.34M | -10.30% |
Total assets | 11.28M | -4.42% |
Total liabilities | 6.88M | -38.74% |
Total equity | 4.41M | — |
Shares outstanding | 5.89M | — |
Price to book | 2.95 | — |
Return on assets | -73.74% | — |
Return on capital | -128.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.86M | -2.68% |
Cash from operations | -3.80M | -50.87% |
Cash from investing | -122.00K | 19.21% |
Cash from financing | — | — |
Net change in cash | -3.92M | -504.75% |
Free cash flow | -2.40M | -61.70% |
About
Founded
2016
Headquarters
Website
Employees
113
